Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease. 2013

Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei 112, Taiwan.

The Severe acute respiratory syndrome coronavirus (SARS-CoV) main protease (M(pro)) cleaves two virion polyproteins (pp1a and pp1ab); this essential process represents an attractive target for the development of anti-SARS drugs. The functional unit of M(pro) is a homodimer and each subunit contains a His41/Cys145 catalytic dyad. Large amounts of biochemical and structural information are available on M(pro); nevertheless, the mechanism by which monomeric M(pro) is converted into a dimer during maturation still remains poorly understood. Previous studies have suggested that a C-terminal residue, Arg298, interacts with Ser123 of the other monomer in the dimer, and mutation of Arg298 results in a monomeric structure with a collapsed substrate-binding pocket. Interestingly, the R298A mutant of M(pro) shows a reversible substrate-induced dimerization that is essential for catalysis. Here, the conformational change that occurs during substrate-induced dimerization is delineated by X-ray crystallography. A dimer with a mutual orientation of the monomers that differs from that of the wild-type protease is present in the asymmetric unit. The presence of a complete substrate-binding pocket and oxyanion hole in both protomers suggests that they are both catalytically active, while the two domain IIIs show minor reorganization. This structural information offers valuable insights into the molecular mechanism associated with substrate-induced dimerization and has important implications with respect to the maturation of the enzyme.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D000086782 Coronavirus 3C Proteases 3C proteases that occur in species of CORONAVIRIDAE. 3C Proteases, Coronavirus,3C-Like Proteinase, Coronavirus,Chymotrypsin-Like Main Protease, Coronavirus,Coronavirus 3C Proteinases,Coronavirus 3CLpro Proteases,Coronavirus 3CLpro Proteinase,M(pro) Protein, Coronavirus,Main Proteinase, Coronavirus,Mpro Protein, Coronavirus,3C Like Proteinase, Coronavirus,3C Proteinases, Coronavirus,3CLpro Proteases, Coronavirus,3CLpro Proteinase, Coronavirus,Chymotrypsin Like Main Protease, Coronavirus,Coronavirus 3C-Like Proteinase,Coronavirus Main Proteinase,Coronavirus Mpro Protein,Proteinase, Coronavirus 3CLpro,Proteinases, Coronavirus 3C
D000086862 Coronavirus M Proteins Viral matrix proteins found in species of CORONAVIRIDAE. Coronavirus M Protein,Coronavirus Membrane Proteins,M Protein, Coronavirus,Coronavirus Matrix Proteins,Coronavirus Membrane Glycoproteins,M Proteins, Coronavirus,Matrix Proteins, Coronavirus,Membrane Glycoproteins, Coronavirus,Membrane Proteins, Coronavirus
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014763 Viral Matrix Proteins Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell. Membrane Proteins, Viral,Viral M Proteins,Viral M Protein,Viral Membrane Proteins
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D045473 Severe acute respiratory syndrome-related coronavirus A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus. HCoV-SARS,SARS Virus,SARS-Associated Coronavirus,SARS-CoV,SARS-CoV-1,SARS-like coronavirus,SARSr-CoV,SARSrCoV,Sarbecovirus,Severe Acute Respiratory Syndrome Virus,Severe acute respiratory syndrome coronavirus,SARS Coronavirus,SARS-Related Coronavirus,Urbani SARS-Associated Coronavirus,Coronavirus, SARS,Coronavirus, SARS-Associated,Coronavirus, SARS-Related,Coronavirus, Urbani SARS-Associated,SARS Associated Coronavirus,SARS Related Coronavirus,SARS like coronavirus,SARS-Associated Coronavirus, Urbani,SARS-like coronaviruses,SARSrCoVs,Sarbecoviruses,Severe acute respiratory syndrome related coronavirus,Urbani SARS Associated Coronavirus

Related Publications

Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
May 2008, Journal of virology,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
April 2021, Scientific reports,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
December 2006, Biochemistry,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
May 2006, FEBS letters,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
January 2006, Current topics in medicinal chemistry,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
February 2021, Biophysical journal,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
March 2022, Communications biology,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
May 2004, Biochemistry,
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
January 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Cheng Guo Wu, and Shu Chun Cheng, and Shiang Chuan Chen, and Juo Yan Li, and Yi Hsuan Fang, and Yau Hung Chen, and Chi Yuan Chou
January 2022, ChemMedChem,
Copied contents to your clipboard!